USE OF CORTICOSTEROID HIP JOINT INJECTIONS IN SPONDYLOARTHRITIS PATIENTS UNDER TNF ALPHA INHIBITORS

被引：0
|
作者：
Maatallah, K. [1 ]
Ben Ouhiba, A. [1 ]
Mahmoud, I. [2 ]
Belghali, S. [3 ]
Hamdi, W. [1 ]
Kchir, M. [1 ]
Tekaya, R. [2 ]
Abdelmoula, L. [2 ]
机构：
[1] MT Kassab Inst, Dept Rheumatol, Tunis, Tunisia
[2] Charles Nicolle Hosp, Dept Rheumatol, Tunis, Tunisia
[3] Farhat Hached Hosp, Dept Rheumatol, Tunis, Tunisia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.6177
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0373
引用
收藏
页码：347 / 347
页数：1
相关论文
共 50 条
  • [31] USE OF TNF-INHIBITORS BEFORE, DURING AND THE FIRST YEAR AFTER PREGNANCY IN WOMEN WITH SPONDYLOARTHRITIS
    Bjorngaard, H.
    Koksvik, H.
    Jakobsen, B.
    Wallenius, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 723 - 723
  • [32] Periprosthetic Joint Infection in Patients Receiving TNF alpha Antagonists
    Snir, Nimrod
    Schwarzkopf, Ran
    Sobieraj, Michael
    Lovy, Andrew J.
    Slover, James D.
    BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2014, 72 (04): : 253 - 258
  • [33] PREVALANCE OF HIP ARTHRITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH TNF INHIBITORS
    Konsta, M.
    Nurmohamed, M. T.
    van denderen, J. C.
    Visman, I
    van der Horst-Bruinsma, I. E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 775 - 775
  • [34] The Use of Hyaluronic Acid and Corticosteroid Injections Among Medicare Patients With Knee Osteoarthritis
    Koenig, Karl M.
    Ong, Kevin L.
    Lau, Edmund C.
    Vail, Thomas P.
    Berry, Daniel J.
    Rubash, Harry E.
    Kurtz, Steven
    Bozic, Kevin J.
    JOURNAL OF ARTHROPLASTY, 2016, 31 (02): : 351 - 355
  • [35] THE ROLE OF BASELINE CONCOMITANT USE OF CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS WITH TNF INHIBITORS IN SPONDYLOARTHRITIS PATIENTS
    Akar, S.
    Kiraz, S.
    Gercik, O.
    Ertenli, I.
    Kucuksahin, O.
    Dalkilic, E.
    Bes, C.
    Kasifoglu, T.
    Emmungil, H.
    Koca, S. S.
    Cinar, M.
    Yazisiz, V.
    Dincer, B. Kelesoglu
    Ates, A.
    Kanitez, N. Alpay
    Erten, S.
    Turan, S.
    Pehlivan, Y.
    Oz, B.
    Bilge, S. Yasar
    Erden, A.
    Armagan, B.
    Coskun, B. N.
    Kalyoncu, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1012 - 1013
  • [36] SERUM LEVELS OF TNF ALPHA AND VEGF AS MARKERS OF DISEASE ACTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
    Mahendran, B.
    Sankalingam, R.
    Mohanasundaram, K.
    Sankaran, S.
    Mani, M.
    Chilukuri, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 328 - 328
  • [37] ASAS recommendations on the use of TNF inhibitors for patients with axial spondyloarthritis. Evaluation of the 2010 update in the German-speaking area
    Kiltz, U.
    Sieper, J.
    Braun, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (01): : 81 - 88
  • [38] Tuberculosis in patients receiving treatment of TNF-alpha inhibitors
    Borekci, Sermin
    Yilmaz, Deniz Demir
    Atahan, Ersan
    Ozguler, Yesim
    Musellim, Benan
    Hamuryudan, Vedat
    Ongen, Hurrem Gul
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [39] Adherence to TNF-alpha inhibitors in patients with hidradenitis suppurativa
    Thomsen, Simon Francis
    Sand, Freja Laerke
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (01) : 97 - 98
  • [40] First consensus document of the Spanish Society of Rheumatology on the use of TNF-alpha antagonists in spondyloarthritis
    Batlle, Enrique
    Canete Crespillo, Juan de Dios
    Collantes, Eduardo
    Luis Fernandez-Sueiro, Jose
    Figueroa, Manuel
    Gonzalez-Fernandez, C.
    Gratacos, Jordi
    Juanola Roura, Xavier
    Martin-Mola, Emilio
    Mulero, Juan
    Sanmarti i Sala, Raimon
    Tornero, Jesus
    Carlos Torre-Alonso, Juan
    Zarco, Pedro
    REUMATOLOGIA CLINICA, 2005, 1 (01): : 32 - 37
12345